更正：里加蒙蒂等人。天冬氨酸转氨酶与血小板比值指数（APRI）在预测重度肥胖儿童和青少年非酒精性脂肪性肝病（NAFLD）中的作用。2022年，，155。
Correction: Rigamonti et al. The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents. 2022, , 155.
作者信息
Rigamonti Antonello E, Bondesan Adele, Rondinelli Eugenia, Cella Silvano G, Sartorio Alessandro
机构信息
Department of Clinical Sciences and Community Health, University of Milan, 20129 Milan, Italy.
Experimental Laboratory for Auxo-Endocrinological Research, IRCCS, Istituto Auxologico Italiano, 28824 Verbania, Italy.
出版信息
Metabolites. 2022 Jun 17;12(6):555. doi: 10.3390/metabo12060555.
Abstract
In the original publication [...].
摘要
在原始出版物中[...]。
相似文献
1
Correction: Rigamonti et al. The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents. 2022, , 155.更正：里加蒙蒂等人。天冬氨酸转氨酶与血小板比值指数（APRI）在预测重度肥胖儿童和青少年非酒精性脂肪性肝病（NAFLD）中的作用。2022年，，155。
Metabolites. 2022 Jun 17;12(6):555. doi: 10.3390/metabo12060555.
2
The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents.天冬氨酸转氨酶与血小板比值指数（APRI）在预测重度肥胖儿童和青少年非酒精性脂肪性肝病（NAFLD）中的作用
Metabolites. 2022 Feb 8;12(2):155. doi: 10.3390/metabo12020155.
3
Relationship between aspartate aminotransferase-to-platelet ratio index and carotid intima-media thickness in obese adolescents with non-alcoholic fatty liver disease.非酒精性脂肪性肝病肥胖青少年中天冬氨酸氨基转移酶与血小板比值指数与颈动脉内膜中层厚度的关系
J Clin Res Pediatr Endocrinol. 2013 Sep 10;5(3):182-8. doi: 10.4274/Jcrpe.891.
4
5
FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran.在伊朗班达尔阿巴斯，比较 FIB-4、APRI 和 AST/ALT 比值与 FibroScan 用于评估非酒精性脂肪性肝病患者的肝纤维化。
BMC Gastroenterol. 2021 Dec 3;21(1):453. doi: 10.1186/s12876-021-02038-3.
6
Evaluation of Six Noninvasive Methods for the Detection of Fibrosis in Chinese Patients with Obesity and Nonalcoholic Fatty Liver Disease.评估六种无创方法在诊断中国肥胖合并非酒精性脂肪性肝病患者肝纤维化中的价值。
Obes Surg. 2022 Nov;32(11):3619-3626. doi: 10.1007/s11695-022-06251-1. Epub 2022 Sep 7.
7
Most overweight and obese Indian children have nonalcoholic fatty liver disease.大多数超重和肥胖的印度儿童患有非酒精性脂肪性肝病。
Ann Hepatol. 2016;15(6):853-861. doi: 10.5604/16652681.1222101.
8
Comparison of the Modified TyG Indices and Other Parameters to Predict Non-Alcoholic Fatty Liver Disease in Youth.改良TyG指数与其他参数在预测青少年非酒精性脂肪性肝病中的比较
Biology (Basel). 2022 Apr 29;11(5):685. doi: 10.3390/biology11050685.
9
Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population.在城市贫民窟居住人群中，天冬氨酸转氨酶与血小板比值指数（APRI）而非FIB-5或FIB-4在排除非酒精性脂肪性肝病（NAFLD）患者的显著纤维化方面是准确的。
BMJ Open Gastroenterol. 2019 Jun 7;6(1):e000288. doi: 10.1136/bmjgast-2019-000288. eCollection 2019.
10
FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis.纤维扫描天门冬氨酸转氨酶：诊断高危代谢功能障碍相关脂肪性肝炎的一种更优的非侵入性模型。
World J Gastroenterol. 2024 May 14;30(18):2440-2453. doi: 10.3748/wjg.v30.i18.2440.
本文引用的文献
1
The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents.天冬氨酸转氨酶与血小板比值指数（APRI）在预测重度肥胖儿童和青少年非酒精性脂肪性肝病（NAFLD）中的作用
Metabolites. 2022 Feb 8;12(2):155. doi: 10.3390/metabo12020155.
Zotero 插件